For what its worth , and keep in mind this does not include the additional Chi-x volumes , the last 4 trading sessions including the 2 just before the trading halt - which were in beginning order of ASX volume 16,339,173 , 37,926,610,124,302,080 , and 33,552,719. So these together with the additional volume of 73,879,156 coming from Chi-x on the largest trading day. This would then represent = 285,999,738 ( 212,120, 582 without Chi-x )And if we look at Chi-x for that single BIGGEST day of 73,879,156 we can see it was about 37% of the total combined volumes or 60% that of ASX on that day. So applying this factor to the ' unkonwn ' volumes on the other 3 days , we can approximate another 52,691,101 shares being added the ' known ' total of 285,999,738 ( ie 60% x 87,818,502 ) .So we now have a theoretical close approximation of 338,690,839 RGL shares being turned over in volume in just 4 days. So then if you make the assumption that every single share traded was turned over , traded , and flipped THREE times , you would then have 42,336,355 or 17.1% of the previous 247,253,716 shares on issue changing hands and / or in new hands or indeed ADDED to existing holdings.If they only traded , or were churned TWICE for every single traded share , this would then be a total of 84,672,710 shares being churned or a massive 34.2 % of the the total SOI being churned and finding itself in other hands.So I guess the BIGGER question for me is how much has been churned as against how much as been accumulated . So even if the whole Top 20 holdings were to have been ' churned ' out .....only to then be re-acquired back through the capital raise - they ( the Top 20 ) would still only have roughly HALF of what they had prior to the raise. And we know that this is not how it's done , nor is it how Top 20 holders mostly view their investmentsSot the mere fact that Tolga has purchased 13,086,727 BEFORE the raise , and is also very likely to be participating in the actual raise - is to me more of a key point to consider at he present moment. And these are the reason's I am taking the opportunity to add more to my original and earlier purchases - particularly at what i would consider these significantly discounted prices relative to RGL's market capitalization and quality of tenements , projects , and resources.......
- Forums
- ASX - By Stock
- Ann: Becoming a substantial holder Tolga Kumova
For what its worth , and keep in mind this does not include the...
-
-
- There are more pages in this discussion • 263 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add RGL (ASX) to my watchlist
|
|||||
Last
0.7¢ |
Change
0.001(16.7%) |
Mkt cap ! $8.467M |
Open | High | Low | Value | Volume |
0.8¢ | 0.8¢ | 0.7¢ | $259.8K | 34.17M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
9 | 4299526 | 0.7¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
0.8¢ | 6686426 | 13 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
9 | 4299526 | 0.007 |
22 | 7999263 | 0.006 |
37 | 15681851 | 0.005 |
13 | 7299444 | 0.004 |
11 | 13946667 | 0.003 |
Price($) | Vol. | No. |
---|---|---|
0.008 | 6686426 | 13 |
0.009 | 6945497 | 15 |
0.010 | 3739626 | 9 |
0.011 | 3192850 | 7 |
0.012 | 185635 | 2 |
Last trade - 16.10pm 15/07/2024 (20 minute delay) ? |
Featured News
RGL (ASX) Chart |
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online